Mazdutide anti-obesity drug achieves 11.7% body weight loss at 12-weeks
Innovent Biologics has announced that the results of a phase 1b study of mazdutide (IBI362), a glucagon-like peptide-1 (GLP-1) and...
top of page
Browse by category
Search
Browse by tag
bottom of page